Clinical Trial

Virtual Reality Rehabilitation for Cognitive, Emotional, and Motor Recovery in Neurological Disorders

Study acronym: NeuroVR
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This randomized controlled trial (RCT) evaluates the effectiveness of virtual reality (VR) rehabilitation in improving cognitive, emotional, social, and motor functions in patients with neurological disorders (ABI, SCI, MS, PD). It investigates whether VR improves motor and cognitive functions more than traditional therapy, identifies neurophysiological changes (EEG, fNIRS, MRI), and assesses the integration of VR with NIBS or telerehabilitation. Conducted over three years at IRCCS Centro Neurolesi Bonino Pulejo, participants are randomly assigned to either a VR training group or an active control group receiving traditional rehabilitation. Procedures include baseline assessments (T0), 20 rehabilitation sessions over 8 weeks, post-intervention evaluations (T1), and a 3-month follow-up (T2). Primary outcomes measure motor and cognitive function (MoCA, MMSE, FIM, TUG, Berg Balance Scale), neurophysiological changes (EEG, MRI, fNIRS, motion analysis), and emotional/social function (Empathy Quotient, Hamilton Depression Scale).
Trial Details
NCT Number NCT06838975
Lead Sponsor IRCCS Centro Neurolesi Bonino Pulejo
Conditions Acquired Brain Injuries, Spinal Cord Injury, Multiple Sclerosis, Parkinson Disease
Enrollment 328 participants
Start Date 2025-01-16
Primary Completion 2027-09-29 (estimated)
Study Completion 2028-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-21